Back
Neurocrine Biosciences Stock Predictions
Sponsored
NBIX
Sponsored
7 Powerhouse Stocks to Buy and Hold Forever
Get it now.
Buy
70
NBIX
Neurocrine Biosciences
Last Price:
137.49
Seasonality Move:
8.72%
7 Day Trial
ALL ACCESS PASS
$
7
9,530x the last time this happened
Here's what our expert says you should buy before April 14.Neurocrine Biosciences Stock Forecast
- Over the next 52 weeks, Neurocrine Biosciences has on average historically risen by 31.3% based on the past 27 years of stock performance.
- Neurocrine Biosciences has risen higher in 17 of those 27 years over the subsequent 52-week period, corresponding to a historical accuracy of 62.96%
-
Is Neurocrine Biosciences Stock Undervalued?
The current Neurocrine Biosciences [NBIX] share price is $137.48. The Score for NBIX is 70, which is 40% above its historic median score of 50, and infers lower risk than normal. - NBIX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
Will Neurocrine Biosciences Stock Go Up Next Year?
- Over the next 52 weeks, Neurocrine Biosciences has on average historically risen by 31.3% based on the past 27 years of stock performance.
Neurocrine Biosciences Stock Rating
Buy
70
Neurocrine Biosciences (NBIX)
is a Buy
Is Neurocrine Biosciences overpriced?
- Neurocrine Biosciences has risen higher in 17 of those 27 years over the subsequent 52-week period, corresponding to a historical accuracy of 62.96%
Neurocrine Biosciences Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
neurocrine.com
52-Week Data
52-Week High:
148.37
52-Week Low:
89.04
Prediction Charts
Market Cap:
13.68B
Price in USD:
137.48
Volume:
800.99K
Beta:
0.78
Technical Analysis
SMA50:
136.76
SMA100:
134.38
SMA200:
121.82
52-Wk Change:
36.06%
Stock Predictions
-
Is Neurocrine Biosciences stock public?
Yes, Neurocrine Biosciences is a publicly traded company. -
What is the Neurocrine Biosciences stock quote today?
The Neurocrine Biosciences stock price is 137.48 USD today. -
How to buy Neurocrine Biosciences stock online?
You can buy Neurocrine Biosciences shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Apr-11 | 138.03 | 135.93 | 138.67 | 135.28 |
Apr-12 | 136.22 | 134.65 | 137.78 | 134.63 |
Apr-15 | 134.97 | 131.74 | 137.00 | 131.52 |
Apr-16 | 131.78 | 132.99 | 135.18 | 131.49 |
Apr-17 | 133.11 | 133.37 | 134.44 | 131.36 |
Apr-18 | 133.23 | 132.54 | 134.20 | 131.00 |
Apr-19 | 132.65 | 131.96 | 133.65 | 130.13 |
Apr-22 | 132.48 | 133.70 | 134.18 | 131.79 |
Apr-23 | 141.00 | 140.25 | 145.00 | 139.22 |
Apr-24 | 140.89 | 138.97 | 144.70 | 138.01 |
Apr-25 | 139.37 | 137.76 | 139.37 | 136.06 |
Apr-26 | 137.47 | 135.99 | 138.63 | 135.17 |
Apr-29 | 136.05 | 138.89 | 139.37 | 136.05 |
Apr-30 | 138.07 | 137.48 | 140.47 | 137.34 |
Neurocrine Biosciences Earnings
Neurocrine Biosciences Earnings Report: Per Share Neurocrine Biosciences Earnings Q1 Q2 Q3 and Q4 last year and next year.
Neurocrine Biosciences Forecast Revenue Growth
Neurocrine Biosciences Stock Analysis: Historical quarterly revenues per share for Neurocrine Biosciences and historical quarterly revenue growth:
- Analysts estimate an earnings increase this quarter of $0.29 per share, a decrease next quarter of $0.10 per share, an increase this year of $1.88 per share, and an increase next year of $1.78 per share.
* Neurocrine Biosciences stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.